NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . December 1st, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Ardea Biosciences, Inc. - Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Third Quarter and Year-to-Date 2008 Financial Results

Epeius Biotechnologies - Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies

Oncology - Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain

Radius Health - Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million

Brain Metastasis - Studies from Royal Marsden Hospital yield new information about brain metastasis

Cancer - Investigators at Addenbrooke's Hospital release new data on cancer

Cancer - Researchers from Kyorin University, Medical Department detail findings in cancer

Cancer Vaccines - Research on cancer vaccines reported by A. Berntsen et al

Enzyme Research - Research from GlaxoSmithKline, Collegeville yields new findings on enzyme research

Melanoma - Research on melanoma described by scientists at University of Virginia

Non-Hodgkin Lymphoma - Investigators at Mayo Clinic release new data on non-hodgkin lymphoma

Tuberculosis - Researchers at Johns Hopkins University have published new data on tuberculosis

Breast Cancer Prognosis - Findings in breast cancer prognosis reported from J.Y. Pierga and co-researchers

Breast Cancer Therapy - Study findings on breast cancer therapy are outlined in reports from T.H. Luu and colleagues

Cancer Clinical Trial - New cancer clinical trial findings from SAIC-Frederick, Inc. published

Clinical Trial Research - Research reports from University of Sao Paulo, Department of Restorative Dentistry provide new insights into clinical trial research

Colon Cancer Therapy - New findings in colon cancer therapy described from Stanford University, Department of Medicine

Follicular Lymphoma Immunotherapy - Researchers from University of Pittsburgh, Department of Medicine publish findings in follicular lymphoma immunotherapy

HIV/AIDS Clinical Trial - New HIV/AIDS clinical trial study findings recently were reported by researchers at Columbia University, Department of Medicine

Life Sciences - Studies from University of Texas, Health Science Center add new findings in the area of life sciences

Melanoma Therapy - Reports outline melanoma therapy study results from N. Penel et al

Monoclonal Antibodies - Recent findings from Duke University, Department of Surgery highlight research in monoclonal antibodies

Tuberculosis Vaccines - Reports summarize tuberculosis vaccines study results from St. Louis University, Center for Vaccine Development

Affymax, Inc. - Affymax Completes Enrollment in EMERALD 1, the Third of Four Phase 3 Clinical Trials of Hematide to Treat Anemia in Chronic Renal Failure Patients

Arete Therapeutics Inc. - Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series a Financing

Avexa Limited - Avexa Presents Data from Apricitabine and Antibacterial Programs at two International Conferences

Bavarian Nordic A/S - Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE Data to the U.S. Health Authorities

Biotechnology Business - Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to the U.S. Health Authorities

Breast Cancer - Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology

Clinical Trial Research - Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting

Clinical Trial Research - Duska Therapeutics Applies for Phase 3 Special Protocol Assessment

HIV/AIDS - Long-Term TITAN Study Evaluates PREZISTA(R)/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults

Leukemia - Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351

Lower Back Pain - Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED-1077

Marketing and Licensing Agreements - Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting

Monoclonal Antibodies - PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing

Non-Small Cell Lung Cancer - Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer

Obesity and Diabetes - Metabolex Announces Positive Results from Phase 2 Clinical Trial of MBX-8025

Schizophrenia - Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia

Vical Incorporated - Vical Announces Strategic Restructuring and Staff Reduction

Xytis, Inc. - Xytis to Initiate First-In-Class Phase I Clinical Trials with Alpha 7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator XY4083



Return to Top of Page

-----------------------
PR Login